Health Outcomes of Parents With Cystic Fibrosis-Aim 2
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- University of Pittsburgh
- Study ID
- NCT06296394
- Status
- Recruiting
Conditions
- Cystic Fibrosis
- Parenthood Status
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Parenthood — OTHERThe intervention group will consist of participants who became first time parents to children under 5 years of age.
Study Details
The goal of this observational prospective study is to determine the health impact of parenthood on United States (US) people with CF in the era of CF transmembrane regulator protein (CFTR) modulators. The investigators will collect physical and mental health data to comprehensively evaluate the impact of parenthood in CF with widespread highly effective CFTR modulator use. The main hypotheses this study aims to examine are: H1: Parents with CF and moderate-to-severe depression have more rapid change in ppFEV1 (percent predicted forced expiratory volume in one second) versus those with mild or no depression. H2: Parents with CF who have more parental responsibility and/or stress have more rapid ppFEV1 (percent predicted forced expiratory volume in one second) change than those with less responsibility/stress H3: Parents using CFTR modulators have decreased ppFEV1 (percent predicted forced expiratory volume in one second) change versus those not using CFTR modulators Participants will complete quarterly surveys during the first year of parenthood and biannual surveys, thereafter, using the computer-based survey system on an iPad protected for infection control or via personal device or computer via emailed survey link.
Key Dates
- Start date
- May 29, 2024
- Status verified
- Nov 2025
- Primary completion
- Feb 1, 2030
- Completion
- Feb 1, 2031
Study Design
- Enrollment
- 146 participants (estimated)
Primary Outcome Measure
Forced Expiratory Volume (FEV1) [ Time Frame: Annually from 2 Years prior to enrollment and annually for Year 1 through Year 5 ]
Central Contacts
- Olivia M Stransky, MPH412-648-4701
Locations (18)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Alabama-Birmingham | Birmingham | Alabama | 35294 | George M Solomon, MD (PRINCIPAL_INVESTIGATOR) |
| National Jewish Health | Denver | Colorado | 80206 | Alexandra Wilson Jennifer Taylor-Cousar, MD, MSCS (PRINCIPAL_INVESTIGATOR) |
| Northwestern University | Evanston | Illinois | 60208 | Manu Jain, MD (PRINCIPAL_INVESTIGATOR) |
| Indiana University | Indianapolis | Indiana | 46202 | Cynthia Brown, MD (PRINCIPAL_INVESTIGATOR) |
| University of Kansas Medical Center | Kansas City | Kansas | 66160 | Megan Behrman Amanda Bruce, PhD (PRINCIPAL_INVESTIGATOR) |
| Johns Hopkins University | Baltimore | Maryland | 21218 | Shivani Patel Natalie West, MD, MPH (PRINCIPAL_INVESTIGATOR) |
| Boston Children's Hospital/Brigham and Women's Hospital | Boston | Massachusetts | 02115 | Jonathan Greenberg Manuela Cernadas, MD (PRINCIPAL_INVESTIGATOR) |
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | Nivedita Chaudhary Anna Georgiopoulos, MD (PRINCIPAL_INVESTIGATOR) |
| University of Michigan | Ann Arbor | Michigan | 48109 | Shijing Jia, MD (PRINCIPAL_INVESTIGATOR) |
| University of Minnesota | Minneapolis | Minnesota | 55455 | Dena Johnson Joanne Billings, MD, MPH (PRINCIPAL_INVESTIGATOR) |
| Washington University School of Medicine | St Louis | Missouri | 63110 | Daniel Rosenbluth, MD (PRINCIPAL_INVESTIGATOR) |
| University of North Carolina | Chapel Hill | North Carolina | 27599 | Elisabeth Dellon Elisabeth Dellon, MD, MPH (PRINCIPAL_INVESTIGATOR) |
| Oregon Health and Science University | Portland | Oregon | 97239 | Aaron Trimble, MD (PRINCIPAL_INVESTIGATOR) |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | Denis Hadjiliadis, MD, PhD (PRINCIPAL_INVESTIGATOR) |
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15213 | - |
| Medical University of South Carolina | Charleston | South Carolina | 29425 | Patrick Flume, MD (PRINCIPAL_INVESTIGATOR) |
| University of Texas-Southwestern | Dallas | Texas | 75390 | Ashley Keller Raksha Jain, MD (PRINCIPAL_INVESTIGATOR) |
| University of Washington | Seattle | Washington | 98195 | Roshni Prabhu Kathleen Ramos, MD, MS (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Birmingham, AL
Related Studies
- Role of Genetic Factors in the Development of Lung DiseaseRecruiting · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland
- Natural History of BronchiectasisRecruiting · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland
- Beta-cell Response to Incretin Hormones in Cystic FibrosisRecruiting · University of Pennsylvania · Philadelphia, Pennsylvania
- Genetics of Insulin and Incretins in Cystic FibrosisRecruiting · Children's Hospital of Philadelphia · Philadelphia, Pennsylvania